Related Experiment Videos
[Radiotherapy of penis and urethral cancers].
Der Urologe. Ausg. A
|January 1, 1986
Summary
Penile carcinoma and urethral cancer treatment requires a stage-dependent approach combining surgery and radiotherapy. Optimal radiation doses (55-60 Gy) achieve 85% local tumor control, preserving surgical options for recurrences.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Context:
- Penile carcinoma and urethral cancers present complex treatment challenges.
- Optimal management strategies require careful consideration of disease stage and patient factors.
Purpose:
- To outline stage-dependent treatment protocols for penile carcinoma and urethral cancer.
- To evaluate the efficacy of combined surgery and radiotherapy, including prophylactic lymph node irradiation.
Summary:
- A combined approach of surgery and radiotherapy is recommended for penile carcinoma, achieving 85% local tumor control with ≥55-60 Gy radiation.
- Prophylactic lymph node irradiation is advised for specific penile and urethral cancer stages (T2+).
- Surgery for recurrences remains feasible after radiotherapy.
Impact:
- Establishes evidence-based guidelines for optimizing oncological outcomes in penile and urethral malignancies.
- Highlights the importance of tailored treatment strategies for improved patient survival and quality of life.